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ABSTRACT The interaction of wild-type and mutant yeast
tRNAfsP transcripts with yeast aspartyl-tRNA synthetase
(AspRS; EC 6.1.1.12) has been probed by using iodine cleavage
of phosphorothioate-substituted transcripts. AspRS protects
phosphates in the anticodon (G34, U35), D-stem (U25), and
acceptor end (G73) that correspond to determinant nucleotides
for aspartylation. This protection, as well as that in anticodon
stem (C29, U40, G41) and D-stem (Ull to U13), is consistent
with direct interaction of AspRS at these phosphates. Other
protection, in the variable loop (G45), D-loop (G18, G19), and
T-stem and loop (G53, U54, U55), as well as enhanced reactivity
at G37, may result from conformational changes of the tran-
script upon binding to AspRS. Transcripts mutated at determi-
nant positions showed a loss of phosphate protection in the
region of the mutation while maintaining the global protection
pattern. The ensemble of results suggests that aspartylation
specificity arises from both protein-base and protein-phosphate
contacts and that different regions oftRNAAw' interact indepen-
dently with AspRS. A mutant transcript of yeast tRNAPbe that
contains the set of identity nucleotides for specific aspartylation
gave a phosphate protection pattern strikingly similar to that of
wild-type tRNAASP. This confirms that a small number of
nucleotides within a different tRNA sequence context can direct
specific interaction with synthetase.
Accurate aminoacylation of tRNAs requires specific inter-
action between tRNA and its cognate aminoacyl-tRNA syn-
thetase (aaRS). The complex of yeast tRNAASP with aspartyl-
tRNA synthetase (AspRS; EC 6.1.1.12) has been studied by
footprinting with a number of probes in solution (1, 2), and a
high-resolution x-ray structure (3) is presently being refined.
As a result, regions of contact between protein and tRNA
were defined; the tRNA interacts with AspRS along the
variable-loop side of the L-shaped tertiary structure, includ-
ing the anticodon loop and stem, the base of the D-stem, and
the 3' extremity of the acceptor stem. Nucleotides function-
ally important for specific aspartylation (Fig. 1) were recently
identified by kinetic analysis of in vitro transcripts (5); they
correspond to nucleotides G34, U35, and C36 in the antico-
don, G73 at the acceptor end, and- base pair G10U25 at the
base of the D-stem. Mutation of these nucleotides resulted in
a dramatic loss of aspartylation activity and suggested that
the wild-type identity nucleotides are in direct contact with
the protein in the enzyme-substrate complex and that these
stabilizing interactions are disrupted upon mutation. Unfor-
tunately, the present state of refinement of the crystal struc-
ture is not sufficient to identify the exact contacts between
tRNA and protein.
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FIG. 1. Cloverleaf structure of wild-type yeast tRNAASP tran-
script containing G1 C72 as first base pair; nucleotides are numbered
according to ref. 4. Nucleotides corresponding to determinants
specific for aspartylation (5) are shaded.
Despite a large number of functional studies on interaction
of mutant or noncognate tRNAs with synthetases (6-8), little
is known about the structural basis of these interactions. In
this paper, we compare the interaction of wild-type and mutant
tRNAASP transcripts with AspRS by using footpninting exper-
iments based on cleavage of phosphorothioate-containing
transcripts by 12; this technique has recently been applied to
the interaction ofEscherichia coli tRNASer and SerRS (9). The
relatively small size and high reactivity of 12 compared with
other phosphate probes such as N-ethyl-N-nitrosourea (ENU)
(10) or aminobenzenediazonium compounds (2) should afford
preferential protection at phosphates in direct contact with
synthetase. Footprint patterns of wild-type tRNAASP tran-
script complexed with AspRS were compared to those of
transcripts individually mutated at determinant nucleotides.
The results show phosphate protection for the wild-type
transcript in the vicinity of determinant nucleotides and local
disruption of RNA-protein interactions in the region of mu-
tated determinant nucleotides, due to either a loss of direct
contact or a local change of conformation.
MATERIALS AND METHODS
Materials. Yeast AspRS (11) and T7 RNA polymerase (12)
were purified according to established procedures. Yeast
Abbreviations: aaRS, aminoacyl-tRNA synthetase; AspRS, etc.,
aspartyl-tRNA synthetase, etc.; ENU, N-ethyl-N-nitrosourea;
NTP[aS], nucleoside 5'-O-(1-thiotriphosphate); phosphorothioate
tRNA transcript, transcript obtained in the presence of an NTP[aS].
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PheRS was a gift of P. Remy (Strasbourg, France), and E. coli
SerRS was a gift of R. Leberman (Grenoble, France). T4
polynucleotide kinase and restriction enzyme BstNI were
from New England Biolabs, bovine alkaline phosphatase was
from Appligene (Strasbourg, France), and 12 was from
Merck. Nucleoside 5'-O-(1-thiotriphosphates (NTP[aS])s,
L-[3H]aspartic acid, and ['y-32P]ATP (3200 Ci/mmol; 1 Ci = 37
GBq) were purchased from Amersham.
Preparation of tRNA Transcripts. Plasmids containing
genes of wild-type and mutant tRNAASP were prepared as
described (5, 13). tRNA transcripts were obtained by incu-
bation ofBstNI-linearized plasmid with T7 RNA polymerase
at 3000 units/ml in 40 mM Tris'HCI, pH 8.1/22 mM MgCl2/1
mM spermidine/5 mM dithioerythritol/0.01% Triton
X-100/40 units of RNAsin (Promega)/4 mM each NTP/0.2
mM one ofthe four NTP[aS]s (5% ofthe corresponding NTP)
for 4 hr at 37°C. Thus, for each plasmid, four transcriptions
with the Sp diastereomer of ATP[aS], CTP[aS], GTP[aS], or
UTP[aS] were performed in parallel, yielding full-length
transcripts containing statistically one phosphorothioate per
molecule (9); transcripts contain phosphorothioates in the Rp
configuration (14, 15). After extraction with phenol and
precipitation with ethanol, transcripts were purified by
HPLC on a TSK-250 column (Bio-Rad) in 0.2 M sodium
acetate, pH 6.5/1% methanol.
The different transcripts were 5'-labeled with polynucle-
otide kinase and purified by electrophoresis on 12% poly-
acrylamide/8 M urea gels. Labeled transcripts were eluted
from the gel, precipitated, and redissolved in a 10 mM
MgCl2/10 mM NaCI/10 mM Hepes-KOH, pH 7.4, buffer.
Aminoacylation Assays. Aspartylation ofthe four wild-type
phosphorothioate transcripts and determination of kinetic
parameters were performed as described (5).
Footprinting. For footprinting experiments, aaRSs were
dialyzed against 10 mM MgCl2/10 mM NaCI/10 mM Hepes-
KOH, pH 7.4, buffer in a Centricon 30 (Amicon). tRNA
transcripts with different phosphorothioates were tested in-
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dividually. All footprinting experiments were performed in 10
,l total volume in 10 mM MgCI2/10 mM NaCI/10 mM
Hepes-KOH, pH 7.4, at 20°C. Unlabeled and labeled tran-
scripts were mixed to give a total concentration of 1 AM and
30,000 cpm (Cerenkov). Yeast AspRS was added to give a
total concentration of 4 ,uM or replaced by 10 mM MgCl2/10
mM NaCI/10 mM Hepes-KOH, pH 7.4, buffer for sequenc-
ing. The concentration of 4 ,uM AspRS assures nearly com-
plete binding (>90%o) for all transcript sequences tested (J.P.,
unpublished results). Transcripts and synthetase were incu-
bated for. 2 min to allow complex formation and were sub-
sequently cleaved by addition of 1 Al of 10 mM 12 in 100%o
ethanol. After 2 min, reactions were stopped by dilution with
40 ,l of 0.4 M sodium acetate, pH 6.0, and extraction with
phenol. The precipitated transcripts were resuspended in 10
Al of 8 M urea/20%o sucrose and dyes, and separated by
denaturing PAGE on 12% polyacrylamide gels. Band inten-
sities in the presence and absence of synthetase were com-
pared and quantitated by laser densitometry of the autora-
diograms. Protection is considered as weak, moderate, or
strong if intensity of bands is decreased 25-50%, 50-75%, or
75-100%o, respectively. To have better accuracy by densi-
tometry, autoradiograms were not overexposed.
Effect of I2 on AspRS Activity. To check the effect of iodine
on AspRS, control experiments were performed with enzyme
pretreated with 12 as described (9).
RESULTS
12 Footprint of Wild-Type Trnscipt Complexed to AspRS.
Footprint experiments were performed on phosphorothioate-
substituted wild-type tRNAASP transcript complexed to yeast
AspRS. Strong differences between the intensities of bands
obtained in the absence and presence ofAspRS (Fig. 2A) reveal
local protection of phosphates in the wild-type transcript by
AspRS. There is no protection in the presence of yeast PheRS
(Fig. 2A) or E. coli SerRS (data not shown), indicating that the
protection found with AspRS is specific. Phosphates discussed
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FIG. 2. Autoradiograms of 12 footprint experiments obtained with 5'-labeled transcript on 12% polyacrylamide denaturing gels. Footprinting
was performed on transcripts substituted with ATP[aS] (A lanes), CTP[aS] (C lanes), GTP[aS] (G lanes), or UTP[aS] (U lanes). Some of the
positions discussed in the text are indicated by arrowheads on the autoradiograms. (A) Wild-type yeast tRNAASP in the absence of synthetase
(-aaRS) or presence of either yeast AspRS (+AspRS) or yeast PheRS (+PheRS). Control lanes 1 and 2, transcript and AspRS or PheRS,
respectively, without 12 treatment. (B) tRNAASP transcript mutated at position 35 (U35 -> A35): Footprints in the absence (-AspRS) or presence
(+AspRS) of yeast AspRS. Control lane, transcript and AspRS without 12 treatment. (C) tRNAPhe transcript with the determinants specific for
aspartylation in the absence (-AspRS) or presence (+AspRS) of yeast AspRS. Control lane as in B.
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in the text are those located 5' to the indicated nucleoside. The
intensity of protection varies; the strongest protection is found
in the anticodon loop (G34, U35). Moderate protection is
observed at the end of the amino acid acceptor arm (G73) and
in the variable loop (G45). Weak protection is found in the
D-loop (G18, G19) and arm (U11, U12, U13, U25), in the
anticodon stem (C29, U40, G41), T-stem, and loop (G53, U54,
U55), and in the acceptor arm (G71). Interestingly, phosphate
at G37 was considerably more accessible in the presence of
AspRS. Phosphates A14, G27, G50, U66, G68, and C69 are
slightly more reactive in the presence of AspRS. Phosphates
protected are shown schematically in Fig. 3A. The unexplained
presence ofa band in theG lane at the position ofC31 in addition
to the corresponding band at position G30 requires the presence
of AspRS as well as a phosphorothioate-substituted guanosine
within the transcript.
Contros. Various control experiments assessed the validity
of the I2 footprint technique. (i) No significant differences were
observed in kinetic parameters (Km and k,) for aspartylation
between phosphorothioate-substituted and nonsubstituted tran-
scripts (data not shown). Since these transcripts are only
minimally substituted (ca. 5%) at each position, this control only
shows that phosphorothioate nucleotides do not grossly affect
the properties of the transcript and not whether the presence of
a phosphorothioate at a specific position disturbs an RNA-
protein interaction (16). (ii) Since I2 can react with certain amino
acids (17), which may be important for the structure or activity
ofthe protein, the protection pattern observed may be due to an
inactive synthetase. AspRS was indeed inactive when treated
Proc. Natl. Acad. Sci. USA 89 (1992)
with 12 and no protection was observed in the presence of
inactive AspRS. Partial activity, consistent with the binding
stoichiometry (18), is retained when the enzyme is complexed
with wild-type transcript before 12 treatment. Thus, interaction
with the transcript blocks AspRS inactivation by 12. (iii) The
lack of protection in the presence of two noncognate syn-
thetases demonstrates that the observed footprint is specific to
AspRS. However, nonspecific complexes or aggregates may
form at the high concentrations ofAspRS and transcript used in
these experiments (18, 19). To eliminate this possibility, foot-
printing experiments were performed on wild-type transcript
over a range of AspRS concentrations (between 40 nM and 4
,uM). All characteristics of the footprint pattern, including
intensifications and the band at position 31, are observed at 0.4
,LM AspRS. Relative band intensities follow a binding curve
similar to that found by filter binding experiments (J.P., unpub-
lished results). Footprint experiments at high AspRS concen-
tration (4 ,uM) but at increased NaCl concentrations (between
10 mM and 100 mM) gave patterns similar to those in low salt,
although the weak protections in the D-bloop (G18, G19) are
reduced at high NaCl concentrations, which preferentially favor
specific complex formation (20).
In summary, these controls demonstrate that the footprint
pattern of tRNAASP transcript complexed to AspRS reflects
the functional interaction between two active molecules, as
shown previously for tRNAser and SerRS (9).
I2 Footprints of Mutant tRNA"P Transcripts Complexed to
AspRS. Footprint experiments were performed on transcripts
bearing single mutations at determinant positions (5). The
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FIG. 3. Phosphates protected by AspRS displayed on the cloverleaf sequences of wild-type yeast tRNAASP transcript (A), of variants mutated
at determinant positions (B-F), and of yeast tRNAPhe containing the determinants specific for aspartylation (G). Untested regions are indicated
by lines. The complete sequence of the wild-type tRNAASP transcript is given. Nucleotides conserved in mutant sequences B-F are indicated
by dots except the determinant nucleotides shown explicitly for each variant. Positions mutated in B-F are shaded. For transplanted tRNAPhe,
the complete sequence is shown and determinants specific for aspartylation are in squares. Phosphates protected in the presence of AspRS are
indicated by triangles. Intensity of protection as determined by densitometry [weak (25-50%), moderate (50-75%), and strong (75-100O)] is
proportional to triangle size. Intensity ofenhancement as determined by densitometry [weak (20-50%6), moderate (50-70%6), and strong (>70%)]
is proportional to asterisk size (strongest enhancement was 86% in wild-type tRNAASP transcript). In wild-type tRNAASP (A), shaded nucleotides
represent nearest proximities with AspRS as visualized by crystallography (3). The loss of aspartylation specificity for tRNA variants expressed
as fold decrease in kcat/Km (5) relative to wild type is given in the box at the lower left ofeach cloverleaf sequence. (H) Quantitative comparison
between footprinting data of tRNAAsP by 12 (left of line) and ENU (right of line) and the regions of tRNA in nearest proximity with AspRS
(shaded). The ENU data are taken from figure 6 in ref. 1 and correspond to the modified tRNA. The extent of protection is proportional to the
length of the arrows [weak (25-50%), moderate (50-75%), and strong (75-100%/)]. No enhancements were found in ENU footprints (1).
(Preliminary ENU footprints on tRNAASP transcripts gave similar results.)
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following mutants were studied: those in which U25 was
changed to C25, G34 to A34, U35 to A35, C36 to U36, and
G73 to U73. A gel corresponding to footprinting experiments
on mutant A35 is shown in Fig. 2B. These results and those
corresponding to the other mutants studied are summarized
in Fig. 3 B-F.
The effect of mutations of determinant nucleotides on the
footprint pattern is localized in the region of the mutated
nucleotide. However, all tRNA mutants did not have the same
behavior. Two different cases were encountered: (i) For
anticodon mutants (G34 mutated to A34, U35 to A35, and C36
to U36), the effect of the single mutation is located not only at
the level of the phosphate belonging to the mutated nucleotide
but also on the whole anticodon loop. A single mutation in the
anticodon induced a loss of protection on several phosphates.
In addition, no strong intensifications were observed at posi-
tion 37; the band at position 31 still appeared. For mutant C25,
some protections are lost in the D-stem and all in the T-stem,
and no strong intensification was observed at G37. (ii) For
mutant U73, mutation induced a perturbation only at the level
of the phosphate belonging to the mutated position; all other
protections and enhancements are still observed, with a
slightly increased reactivity of phosphate 14.
12 Footprints of a Yeast tRNAPhe Transcript Containing
Aspartic Acid Determinants Complexed to AspRS. A yeast
tRNAPhe transcript containing aspartic acid determinants
(U25, U35, C36, and G73; G10 and G34 are already in the
yeast tRNAPhe sequence) is an excellent substrate for AspRS,
whereas the wild-type tRNAPhe transcript is not aspartylated
at a detectable level (5). Footprint experiments were per-
formed on both transcripts to delineate the phosphates in
contact with AspRS and to compare these results with those
obtained with the wild-type tRNAASP transcript.
The wild-type tRNAPhe transcript was only weakly protected
by AspRS. Minor protection was observed at phosphates 34 and
45. The transcript may interact weakly with AspRS to form a
small fraction of complex at high AspRS concentrations. No
intensification at position 37 was observed (results not shown).
The phosphate protection and intensification pattern for the
tRNAPhe transcript with the aspartic acid determinants is strik-
ingly similar to that of wild-type tRNAASP for the strongest
protections and enhancements (Figs. 2C and 3G); the extra
band at position 31 was not observed.
DISCUSSION
The I2-phosphorothioate technique has been previously used to
characterize the interaction oftRNAser with SerRS (9). As with
any footprinting technique (21), interpretation of protection
must proceed with caution. Control experiments demonstrated
that both tRNA and synthetase are active under footprinting
conditions and that all tRNAs are specifically complexed to
AspRS. Certain phosphate positions in transcripts of tRNAASP
are found to be protected in the presence of AspRS. These
include phosphates belonging to nucleotides (U25, G34, U35,
G73) important for tRNAASP identity. The crystal structure of
the complex between tRNAASP and AspRS shows that the
synthetase interacts in the region ofdeterminant nucleotides (3)
(Fig. 3A). The weakly protected phosphates at positions 11, 12,
and 13 in the D-stem as well as positions 29, 40, and 41 in the
anticodon stem correlate with synthetase interaction with these
regions. Because of the relatively small size of 12 as a chemical
probe, strongly protected phosphates are probably in regions of
interaction with synthetase from which solvent is excluded;
these may include phosphates interacting directly with amino
acids in the protein.
A second category of protected phosphates is observed
(G18, G19, G45, G53, U54, U55) that are in regions of the
tRNA clearly not in contact with the synthetase as observed
in the crystal structure (Fig. 3A). Since tRNAASP undergoes
a change in tertiary structure and anticodon conformation
upon binding to the synthetase (3), protection at these
positions may arise from this conformational change. An-
other reason for protection can be the formation of nonspe-
cific aggregates that occurs when the concentration ofAspRS
is in great excess to that of tRNA (18). If so, unspecific
protection would affect positions in the complex that are the
most exposed to the solvent as are residues in the D-loop and
T-arm. The amount of such aggregates is very sensitive to
ionic strength (18), and indeed footprinting control experi-
ments (see above) confirm this view. Thus all protection in an
I2 footprint cannot be assigned a priori to a direct and specific
interaction with the protein.
Enhancement of 12 reactivity is observed at several phos-
phates and is especially strong at position G37; this probably
arises from conformational changes that result in a prefer-
ential geometry for 12 reactivity at the phosphorothioate or a
favorable orientation of the 2'-OH for in-line attack of the
phosphothioester bond (9).
The extra band observed at position 31 in the G-substituted
transcript correlates with the presence of AspRS. This cleav-
age of a normal phosphate (corresponding to C31) requires
the presence of a phosphorothioate-substituted G. Footprint-
ing experiments as well as the crystal structure of the
complex suggest major-groove contacts in this region. The
unknown cleavage mechanism may reflect a protein contact
in this region.
The complex between yeast tRNAASP and AspRS has been
previously characterized by footprinting experiments using
ENU, which also probes phosphate accessibility (1). The two
techniques (12/phosphorothioate and ENU) give similar re-
gions of protection while emphasizing different specific phos-
phates (Fig. 3H). Phosphates in the anticodon stem of native
tRNAASP (G28-U32, C38) as well as phosphate corresponding
to U12 at the base of the D-stem and G45 in the variable loop
are the most strongly protected from ENU modification in the
presence of AspRS. In contrast, only weak protection at C29,
U40, and G41 in the anticodon stem is observed by the 12
technique. Regions of protection by the two techniques over-
lap at the base of the D-stem and at G45. Strong protection is
observed in the anticodon by the 12 technique, but it could not
be tested by ENU footprinting for technical reasons (1). Only
C38 is protected in the anticodon loop by ENU.
The different phosphate protection patterns reflect the
relative strengths and weaknesses of each technique. Phos-
phates protected from ENU in the presence of AspRS are
spread over several nucleotides within a certain region of
tRNAAsP. ENU is much less reactive than I2. The time of
cleavage by the 12 technique is at most 1-2 min, whereas ENU
modifications are performed over a 2-hr time period, with a
very low level of modification. A protein-RNA complex is
dynamic, and kinetic opening of the complex may contribute
to the cleavage pattern if the lifetime of the open I2-accessible
state is significant compared to the 12 reaction rate; this would
increase the number of apparently reactive phosphates in the
complex. In addition, ENU can react with both oxygen atoms
of a phosphate group, whereas I2 reacts with only a single
position, the sulfur atom, of each phosphorothioate group.
Within double-stranded regions of RNA, the substituted
oxygen (pro-Rp) points inward in the narrow major groove
and may not be as accessible for protein contacts as the
pro-Sp oxygen; this may further explain the weak protection
observed in the anticodon stem with the 12 technique. On the
other hand, the presence of a sulfur atom may disturb the
structure of the transcript (22) or interfere with protein-RNA
interactions (16). In the latter case, no protection in the
presence of protein would be observed, even though this
phosphate is in direct contact with the protein in the unsub-
stituted transcript. These points emphasize that the protec-
tion observed with the 12 technique represents a minimum set
of phosphates in possible contact with the synthetase.
Biochemistry: Rudinger et al.
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Specific interaction ofAspRS with tRNAASP likely involves
an array of protein contacts with the bases as well as the
phosphate backbone. In wild-type transcript, phosphates
corresponding to all determinant nucleotides except C36
were protected by AspRS. For determinant mutants, loss of
phosphate protection is observed in the region of the mutated
nucleotide; this suggests a local alteration in the interaction
between tRNA and synthetase. Thus, upon mutation of G73
to U73, protection of phosphate 73 is reduced, but anticodon
loop protection is the same as for the wild-type transcript.
Enhancement at position 37 is observed for this mutant,
suggesting a conformational change similar to that in the
wild-type molecule. In contrast, mutation of anticodon nu-
cleotides causes a reduction of protection at several phos-
phates in the anticodon loop. These results suggest interde-
pendence of protein-base and protein-phosphate contacts,
as observed in specific DNA-protein complexes (23, 24).
The conservation of the overall footprint pattern upon
mutation can be understood if the different regions of the
tRNA in contact with AspRS interact independently with the
protein; mutation of a nucleotide in one region (e.g., G73)
does not affect the RNA-protein interaction in another (e.g.,
anticodon). This may be a consequence of the large spatial
separation between regions of specific interaction; anticodon
nucleotides and the 3'-CCA terminus interact with separate
domains of AspRS (3). In contrast, the loss of several
phosphate protections within the anticodon upon mutation of
a single anticodon nucleotide suggests a greater interdepen-
dence among AspRS interactions with anticodon nucleo-
tides. Interestingly, the number of protections lost in differ-
ent anticodon mutants correlates with the decrease in the
kinetic specificity constant (kcat/Km) for aspartylation (5)
(Fig. 3); mutation of U35 to A35 had the greatest effect on the
footprinting pattern and aspartylation (530-fold decrease in
kca/Km). The available binding energy of these interactions
is mostly used for transition-state stabilization.
Conformational changes of tRNAAsP upon binding AspRS
may contribute to specificity (3). The strongly increased
reactivity of position 37 in all sequences tested correlates
with the presence of the full complement of protections in the
anticodon, since this increased reactivity is reduced or even
not observed in anticodon mutants. The conformational
change of the anticodon in tRNAASP appears related to the
presence of specific contacts with AspRS in the region of the
anticodon. Such contacts would provide the driving force for
conformational change, which would contribute to substrate
discrimination and aspartylation specificity. Interestingly,
the increased reactivities in other parts of the wild-type
molecule that we interpret as conformational changes are also
significantly perturbed in the tRNAAsP variants (Fig. 3).
Conversion of yeast tRNAPhe into an efficient aspartic acid
acceptor is achieved by the mutation of four nucleotides (5).
Strikingly, the phosphate protection pattern of this transcript
in the presence of AspRS closely resembles that of wild-type
tRNAASP transcript. Thus, the interactions of these two
different tRNA sequences appear similar. The same intensi-
fications of phosphate cleavage as in the wild-type tRNAASP
transcript are also observed, which suggests that similar
conformational changes are occurring in the tRNAPhe tran-
script with aspartic acid identity elements as in wild-type
tRNAASP. These experiments graphically illustrate that the
interactions between tRNA and cognate synthetase required
for correct aminoacylation are directed by a small number of
nucleotides (7, 8).
The specific recognition ofnucleotides spatially dispersed in
different regions of tRNA distinguishes tRNA recognition by
Proper aminoacylation in vivo requires discrimination of cog-
nate tRNA from all other tRNAs; the mix of independent
recognition of various tRNA domains by synthetase and more
interdependent contacts with a certain domain may influence
the number of specific interactions required for this discrim-
ination. Recognition oftRNA regions, in particular the 3'-CCA
extremity and anticodon, by different protein domains (25)
may be an important factor in aaRS evolution (26).
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